Segment Information (Tables)

12 Months Ended

Dec. 30, 2023

Segment Reporting [Abstract]

Schedule of Segment Information

The following tables present our segment information (in $000’s):

	For the Years Ended
	December 30, 2023		December 31, 2022
Revenues
Biotechnology	$	—	$	—
Discontinued operations	3,795		39,611
Total Revenues	$	3,795	$	39,611
Gross profit
Biotechnology	$	—	$	—
Discontinued operations	(197)		7,619
Total Gross profit	$	(197)	$	7,619
Operating income
Biotechnology	$	(19,846)	$	(3,149)
Discontinued operations	10,438		8,395
Total Operating income	$	(9,408)	$	5,246
Depreciation and amortization
Biotechnology	$	1,452	$	2
Discontinued operations	96		555
Total Depreciation and amortization	$	1,548	$	557
Interest income (expense), net
Biotechnology	$	2,250	$	468
Discontinued operations	(181)		(957)
Total Interest income (expense), net	$	2,069	$	(489)
Net income after provision for income taxes
Biotechnology	$	(17,095)	$	8,020
Discontinued operations	9,283		2,972
Total Net income after provision for income taxes	$	(7,812)	$	10,992

	As of December 30, 2023		As of December 31, 2022
Assets
Biotechnology	$	18,487	$	29,165
Discontinue operations	—		17,591
Total Assets	$	18,487	$	46,756
Intangible Assets
Biotechnology	$	17,846	$	19,297
Discontinued operations	—		735
Total Intangible Assets	$	17,846	$	20,032